Annual Drug Patent Expirations for ARMONAIR+DIGIHALER
Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-three patents protecting this drug.
Drug patent litigation for ARMONAIR DIGIHALER.
This drug has eigthy-three patent family members in eighteen countries.
The generic ingredient in ARMONAIR DIGIHALER is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
